MSOXAdvisorShares MSOS Daily Leveraged ETF
Seeks daily investment results that correspond to approximately 200% of the daily total return of the US Cannabis ETF.
By AdvisorShares · Launched 2022
Annual Cost
0.97%
#5,177 of 6,040 · expensive
Fund Size
$66M
#3,466 of 6,040 · mid-size
Return (1Y)
-76.6%
Track Record
4 years
#2,705 of 6,040 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$2,126-78.7%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundHoldings
By weightConcentration
synthetic exposure — holdings shown are derivatives collateral, not the fund's positions
CLEAR STREET LLC
4.6%
BLACKROCK TREASURY TRUST
1.7%
AdvisorShares Trust
0.0%
COWEN INC.
-1.7%
COWEN INC.
-10.1%
Asset allocation
Cash
81.2%
Other
18.0%
Bonds
0.8%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
169.8%High
Year-on-year price swings
Max drawdown
-99.9%Severe
Worst peak-to-trough loss
Sharpe (3Y)
-0.17Below average
Sortino (3Y)
-0.25Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks daily investment results that correspond to approximately 200% of the daily total return of the US Cannabis ETF.
- Strategy
- Actively managed ETF aiming for 2x daily returns of the US Cannabis ETF through swap agreements. Concentrates at least 25% in pharmaceuticals, biotechnology & life sciences within the health care sector, focusing on mid- and small-cap companies in the U.S. cannabis market.
- Inception date
- August 23, 2022
- Fund family
- AdvisorShares
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save MSOX to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18